AI-driven non-coding RNA networks: unlocking a new dimension in precision medicine for lung cancer
Cancer Advances · 2026 · 9 · e26016
DOI: 10.53388/2026926016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Advances, 2026. Verfasst von Rui Shen und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Lung cancer remains the leading cause of cancer-related mortality worldwide [1]. Its high molecular heterogeneity, coupled with complex mechanisms of drug resistance, continues to pose substantial challenges for precision medicine. In recent years, non-coding RNAs (ncRNAs) — once regarded as mere transcriptional byproducts — have emerged as key regulators of tumor biology, revealing new dimensions of regulatory complexity. Concurrently, the rapid advancement of artificial intelligence (AI) is transforming our capacity to decipher such complexity. The synergy between these two rapidly evolving fields holds great promise for reshaping the diagnostic and therapeutic landscape of lung cancer. Our understanding of ncRNA function has evolved
Zitieren
APA
Shen, R., & Gong, Z. (2026). AI-driven non-coding RNA networks: unlocking a new dimension in precision medicine for lung cancer. Cancer Advances, 9(0), e26016. https://doi.org/10.53388/2026926016
Vancouver
Shen R, Gong Z. AI-driven non-coding RNA networks: unlocking a new dimension in precision medicine for lung cancer. Cancer Advances. 2026;9(0):e26016. doi:10.53388/2026926016
BibTeX
@article{Shen2026,
author = {Shen, Rui and Gong, Zhao-Hui},
title = {AI-driven non-coding RNA networks: unlocking a new dimension in precision medicine for lung cancer},
journal = {Cancer Advances},
year = {2026},
volume = {9},
number = {0},
pages = {e26016},
doi = {10.53388/2026926016}
}
EUVIMED